Thanks Red bar,
BL stated to me in an email before the current release of the excellent Breath Easy blind trial data, that the RAP team are using all the data including the rejected data and failed data from last year to fine tune the Resapp Algorithm.
It is my belief that this will be happening as I write this.
I believe the RAP team will be doing further fine tuning including the less than 3% rejected data and the already released excellent Australian data, before the US pediatric data is tested.
It is because of this that my belief in the above is that the US blind trial data will exceed the Australian Breath Easy data results.
I believe that once the US data is released, "Doctors without Borders" will come on board very soon after and paying a nominal License fee for unlimited use in the third world, thus eliminating the need for any CR.
All the above are my opinions and beliefs.
MB
CR required?, page-11
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #